Skip to main content

Eli Lilly and Company United States revenue

  • LLY · NYSE
  • Pharmaceuticals
  • S&P 500
$1443.50+1.14%Close 13 Nov 2026 · Market value $1.36T

United States revenue at Eli Lilly and Company came to $15.1B for the quarter to 30 Sep 2026, up 33.9% from a year earlier.

As Eli Lilly and Company reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 29 Oct 2026.

By quarter

$6.5BDec 2023$5.7BMar 2024$7.8BJun 2024$7.8BSep 2024$9.0BDec 2024$8.5BMar 2025$10.8BJun 2025$11.3BSep 2025$12.9BDec 2025$12.1BMar 2026$14.4BJun 2026$15.1BSep 2026
Eli Lilly and Company United States revenue, every reported period
Period endingUnited States revenueChange on a yearFiled
30 Sep 2026$15.1Bup 33.9%29 Oct 2026
30 Jun 2026$14.4Bup 33.3%5 Aug 2026
31 Mar 2026$12.1Bup 42.8%30 Apr 2026
31 Dec 2025$12.9Bup 42.6%12 Feb 2026
30 Sep 2025$11.3Bup 44.6%30 Oct 2025
30 Jun 2025$10.8Bup 38.0%7 Aug 2025
31 Mar 2025$8.5Bup 49.1%1 May 2025
31 Dec 2024$9.0Bup 39.9%19 Feb 2025
30 Sep 2024$7.8Bup 45.6%30 Oct 2024
30 Jun 2024$7.8Bup 41.6%8 Aug 2024
31 Mar 2024$5.7Bup 28.4%30 Apr 2024
31 Dec 2023$6.5Bup 38.6%21 Feb 2024
30 Sep 2023$5.4Bup 21.4%2 Nov 2023
30 Jun 2023$5.5Bup 40.6%8 Aug 2023
31 Mar 2023$4.4Bdown 14.3%27 Apr 2023
31 Dec 2022$4.7Bdown 10.0%22 Feb 2023
30 Sep 2022$4.4Bup 10.8%1 Nov 2022
30 Jun 2022$3.9Bup 6.2%4 Aug 2022
31 Mar 2022$5.2Bup 31.3%29 Apr 2022
31 Dec 2021$5.2Bup 12.6%23 Feb 2022
30 Sep 2021$4.0Bup 26.2%27 Oct 2021
30 Jun 2021$3.7Bup 17.8%3 Aug 2021
31 Mar 2021$3.9Bup 18.4%30 Apr 2021
31 Dec 2020$4.6Bup 30.7%17 Feb 2021
30 Sep 2020$3.2Bup 3.3%28 Oct 2020
30 Jun 2020$3.1Bdown 3.3%31 Jul 2020
31 Mar 2020$3.3Bup 15.2%1 May 2020
31 Dec 2019$3.5Bup 7.2%19 Feb 2020
30 Sep 2019$3.1Bdown 0.3%25 Oct 2019
30 Jun 2019$3.3Bup 0.3%2 Aug 2019
31 Mar 2019$2.9Bup 3.4%2 May 2019
31 Dec 2018$3.3Bdown 4.1%19 Feb 2019
30 Sep 2018$3.1Bdown 1.1%6 Nov 2018
30 Jun 2018$3.2Bdown 2.5%25 Jul 2018
31 Mar 2018$2.8Bdown 4.7%27 Apr 2018
31 Dec 2017$3.4B—20 Feb 2018
30 Sep 2017$3.1B—27 Oct 2017
30 Jun 2017$3.3B—28 Jul 2017
31 Mar 2017$2.9B—1 May 2017

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Eli Lilly and Company: Cardiometabolic Health revenue · Zepbound revenue · Mounjaro revenue · Oncology revenue · Verzenio revenue · Immunology revenue · Jardiance revenue · Trulicity revenue · Taltz revenue · Neuroscience revenue · Outside U.S. revenue · Europe revenue · Rest of world revenue · China revenue · Japan revenue · financial statements

Every KPI and segment of LLY, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.